Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs)

Bioorg Med Chem. 1999 Nov;7(11):2283-92. doi: 10.1016/s0968-0896(99)00181-9.

Abstract

A set of TIBO derivatives endowed with reverse transcriptase (RT) inhibitory activity were analyzed by comparative molecular field analysis (CoMFA). Besides conventional steric and electrostatic fields, molecular lipophilicity potential (MLP) was also used as a third field in CoMFA. An informative and statistically significant model (q2 = 0.70, r2 = 0.90, s = 0.46) was obtained by taking into account the three field types together. The key molecular determinants governing the RT inhibition by TIBO congeners were detected at the 3-D level by a careful analysis of the CoMFA isocontour maps. To challenge the predictive ability of the CoMFA model, an external set of thiazolobenzimidazole (TBZ) derivatives were examined. Good predictions, suggesting a similar binding mode for TIBO and TBZ derivatives, emerged. Flexible docking experiments on TBZ, TIBO and other NNIs confirmed common binding characteristics, as found out also by CoMFA, and moreover a good correlation between calculated binding energies and inhibitory potency was found.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzimidazoles / chemistry
  • Benzimidazoles / pharmacology
  • Benzodiazepines / chemistry*
  • Benzodiazepines / pharmacology
  • Crystallography, X-Ray
  • HIV Reverse Transcriptase / antagonists & inhibitors*
  • HIV Reverse Transcriptase / chemistry
  • Imidazoles / chemistry*
  • Imidazoles / pharmacology
  • Models, Chemical
  • Models, Molecular
  • Protein Conformation
  • Reverse Transcriptase Inhibitors / chemistry*
  • Reverse Transcriptase Inhibitors / pharmacology
  • Structure-Activity Relationship
  • Thiazoles / chemistry
  • Thiazoles / pharmacology

Substances

  • Benzimidazoles
  • Imidazoles
  • Reverse Transcriptase Inhibitors
  • Thiazoles
  • Benzodiazepines
  • 1-(2',6'-difluorophenyl)-1H,3H-thiazolo(3,4-a)benzimidazole
  • R 79882
  • HIV Reverse Transcriptase